Adding to the Effectiveness of Intravenous Tissue Plasminogen Activator for Treating Acute Stroke
- 10 June 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (22), 2769-2770
- https://doi.org/10.1161/01.cir.0000069565.43766.ed
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- How Effective Are “Community” Stroke Screening Programs at Improving Stroke Knowledge and Prevention Practices?Stroke, 2003
- Adjuvant Treatment With a Glycoprotein IIb/IIIa Receptor Inhibitor Increases the Therapeutic Window for Low-Dose Tissue Plasminogen Activator Administration in a Rat Model of Embolic StrokeCirculation, 2003
- Early stroke treatment associated with better outcomeNeurology, 2000
- Intra-arterial Prourokinase for Acute Ischemic StrokeJAMA, 1999
- Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled TrialJAMA, 1998
- Reperfusion Injury: Demonstration of Brain Damage Produced by Reperfusion after Transient Focal Ischemia in RatsJournal of Cerebral Blood Flow & Metabolism, 1997
- CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic strokeThe Lancet, 1997
- The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic strokeThe Lancet, 1997
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992